These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


78 related items for PubMed ID: 6514546

  • 1. [Clinical evaluation of radiosensitizing effects of misonidazole].
    Mitsuhashi N, Yonome I, Niibe H, Mogi K, Sakaino K, Nakajima N, Saito K, Suzuki Y, Sudo H, Okazaki A.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1984 Jul 25; 44(7):956-65. PubMed ID: 6514546
    [No Abstract] [Full Text] [Related]

  • 2. [Clinical study on radiotherapy in combination with misonidazole].
    Ono K, Takahashi M, Dodo Y, Abe M.
    Nihon Gan Chiryo Gakkai Shi; 1983 Aug 20; 18(5):1189-99. PubMed ID: 6663172
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical evaluation of misonidazole combined with radiotherapy in the treatment of carcinoma of the esophagus--a double-blind randomized trial].
    Irie G, Sakurai T, Kikuchi Y, Watari T, Ikeda M, Mochizuki S, Kamata R, Kaneda K, Mikuriya S, Sakura M.
    Nihon Gan Chiryo Gakkai Shi; 1984 Oct 20; 19(9):2085-92. PubMed ID: 6397547
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical experiences with the radiosensitizer Misonidazol (author's transl)].
    Bamberg M, Tamulevicius P, Streffer C, Scherer E.
    Strahlentherapie; 1981 Aug 20; 157(8):524-36. PubMed ID: 7268822
    [No Abstract] [Full Text] [Related]

  • 5. Radiosensitizing effect of combined radiotherapy, hyperthermia and misonidazole on C3H mouse FM3A tumor.
    Yamashita M.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1984 Sep 25; 44(9):1181-8. PubMed ID: 6522270
    [No Abstract] [Full Text] [Related]

  • 6. [Postoperative radiotherapy of astrocytomas grade 3 and 4 with the radiosensitizer misonidazole. -End results of a multicentric controlled German study].
    Sack H, Calcanis A, Godehardt E, Weidtman V, Zülch KJ, Ammon J, Bamberg M, Herbst M, Keim H, Kleibel F, Makoski HB, Potthoff PC, Schlegel G, Schnepper E.
    Strahlentherapie; 1982 Aug 25; 158(8):466-9. PubMed ID: 6753245
    [Abstract] [Full Text] [Related]

  • 7. [Clinical trials of hypoxic cell sensitizer misonidazole].
    Onoyama Y.
    Gan No Rinsho; 1983 May 25; 29(6):718-25. PubMed ID: 6348345
    [Abstract] [Full Text] [Related]

  • 8. Clinical trials with hypoxic cell sensitizers-the European experience.
    Dische S.
    Prog Clin Biol Res; 1983 May 25; 132D():293-303. PubMed ID: 6356146
    [No Abstract] [Full Text] [Related]

  • 9. Misonidazole & radiotherapy in the palliative treatment of lung cancer.
    Mameghan H, Heller EH.
    Australas Radiol; 1983 Nov 25; 27(3):246-53. PubMed ID: 6202291
    [No Abstract] [Full Text] [Related]

  • 10. Misonidazole and radiotherapy to treat malignant glioma: a phase II trial of the radiation therapy oncology group.
    Carabell SC, Bruno LA, Weinstein AS, Richter MP, Chang CH, Weiler CB, Goodman RL.
    Int J Radiat Oncol Biol Phys; 1981 Jan 25; 7(1):71-7. PubMed ID: 7263341
    [No Abstract] [Full Text] [Related]

  • 11. The effect of hypoxic radiosensitizer after mild hyperthermia in C3H mammary carcinoma.
    Ohizumi Y, Murayama C, Maezawa H, Mori T.
    Tokai J Exp Clin Med; 1984 Oct 25; 9(4):331-7. PubMed ID: 6537042
    [Abstract] [Full Text] [Related]

  • 12. Combinations of radiation and misonidazole in a murine lung tumor model.
    Siemann DW, Kochanski K.
    Radiat Res; 1981 May 25; 86(2):387-97. PubMed ID: 7232698
    [No Abstract] [Full Text] [Related]

  • 13. [Clinical evaluation of hypoxic cell sensitizer (Misonidazole)].
    Asakawa H, Watarai J, Hoshino T.
    Gan To Kagaku Ryoho; 1984 Jun 25; 11(6):1225-30. PubMed ID: 6732250
    [Abstract] [Full Text] [Related]

  • 14. Palliation of liver metastases with combined hepatic irradiation and misonidazole. Results of a Radiation Therapy Oncology Group Phase I-II study.
    Leibel SA, Order SE, Rominger CJ, Asbell SO.
    Cancer Clin Trials; 1981 Jun 25; 4(3):285-93. PubMed ID: 6169464
    [No Abstract] [Full Text] [Related]

  • 15. [Radiosensitizing effect of the nitroimidazole derivatives RK28 and DNIE on murine tumors].
    Tanaka M, Fukuda H, Nakajima T, Sugimoto K, Onoyama Y, Hori H, Inayama S.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1988 Oct 25; 48(10):1249-60. PubMed ID: 3222139
    [No Abstract] [Full Text] [Related]

  • 16. Misonidazole as a radiosensitizer in the radiotherapy of glioblastomas and oesophageal cancer. Pharmacokinetic and clinical studies.
    Tamulevicius P, Bamberg M, Scherer E, Streffer C.
    Br J Radiol; 1981 Apr 25; 54(640):318-24. PubMed ID: 7013890
    [Abstract] [Full Text] [Related]

  • 17. Misonidazole and radiotherapy in lung cancer: a randomized double-blind trial.
    Mäntylä MJ, Nordman EM, Ruotsalainen PJ, Kylmämaa TT.
    Int J Radiat Oncol Biol Phys; 1982 Oct 25; 8(10):1719-20. PubMed ID: 6759478
    [No Abstract] [Full Text] [Related]

  • 18. [Treatment with misonidazole and high voltage irradiation of xenotransplanted human carcinomas in nu/nu mice with thymic aplasia].
    Kleine W, Stange S, Nagy D, Ladner HA.
    Strahlentherapie; 1982 Aug 25; 158(8):498-503. PubMed ID: 6814020
    [Abstract] [Full Text] [Related]

  • 19. Clinical trials of misonidazole in the United States.
    Wasserman TH, Stetz J, Phillips TL.
    Cancer Clin Trials; 1981 Aug 25; 4(1):7-16. PubMed ID: 7214664
    [Abstract] [Full Text] [Related]

  • 20. A controlled clinical trial of misonidazole in the radiotherapy of patients with carcinoma of the bronchus.
    Saunders MI, Anderson P, Dische S, Martin WM.
    Int J Radiat Oncol Biol Phys; 1982 Aug 25; 8(3-4):347-50. PubMed ID: 7050036
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.